• FDA Clears First Vaginal Ring for 1 Year of Birth Control

    2 monthes ago - By Medscape

    Annovera (segesterone acetate and ethinyl estradiol vaginal system) is the first vaginal ring contraceptive approved that provides a full year of protection against unintended pregnancy.
    FDA Approvals
    Read more ...

     

  • FDA authorizes marketing of fertility awareness app

    2 monthes ago - By Healio

    The FDA has permitted marketing of a fertility awareness app that can be used as a method of contraception.
    This is the first authorization for a direct-to-consumer app for contraceptive use to prevent pregnancy, according to a news release from the FDA.
    The Natural Cycles app, which is intended for use in premenopausal women aged 18 and older, calculates the woman's likelihood of fertility based on daily basal body temperature and menstrual cycle information.
    In clinical studies involving 15,570 women, the app had a “perfect use” failure rate of 1.8% and a “typical use”
    Read more ...

     

  • FDA approves 1-year vaginal ring contraceptive

    2 monthes ago - By Healio

    The FDA today approved a Annovera, a combined hormonal contraceptive for women of reproductive age and the first vaginal ring contraceptive that can be used for an entire year, according to a press release from the agency.
    Annovera (segesterone acetate and ethinyl estradiol vaginal system; The Population Council, Inc.), is a reusable, non-biodegradable, flexible vaginal system that is placed in the vagina for 3 weeks followed by 1 week out of the vagina, at which time women may experience a period. This schedule is repeated every 4 weeks for 1 year (for 13, 28-day
    Read more ...